OpenURL Connection Search

Select item for more details and to access through your institution.

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer.
Published in:
British Journal of Cancer, 2015, v. 112, n. 1, p. 52, doi. 10.1038/bjc.2014.563
By:
- Bazzola, L;
- Foroni, C;
- Andreis, D;
- Zanoni, V;
- R Cappelletti, M;
- Allevi, G;
- Aguggini, S;
- Strina, C;
- Milani, M;
- Venturini, S;
- Ferrozzi, F;
- Giardini, R;
- Bertoni, R;
- Turley, H;
- Gatter, K;
- Petronini, P G;
- Fox, S B;
- Harris, A L;
- Martinotti, M;
- Berruti, A
Publication type:
Article
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.
Published in:
British Journal of Cancer, 2013, v. 108, n. 8, p. 1587, doi. 10.1038/bjc.2013.151
By:
- Allevi, G;
- Strina, C;
- Andreis, D;
- Zanoni, V;
- Bazzola, L;
- Bonardi, S;
- Foroni, C;
- Milani, M;
- Cappelletti, M R;
- Gussago, F;
- Aguggini, S;
- Giardini, R;
- Martinotti, M;
- Fox, S B;
- Harris, A L;
- Bottini, A;
- Berruti, A;
- Generali, D
Publication type:
Article
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.
Published in:
Osteoporosis International, 2008, v. 19, n. 1, p. 113, doi. 10.1007/s00198-007-0423-z
By:
- Dovio, A.;
- Generali, D.;
- Tampellini, M.;
- Berruti, A.;
- Tedoldi, S.;
- Torta, M.;
- Bonardi, S.;
- Tucci, M.;
- Allevi, G.;
- Aguggini, S.;
- Bottini, A.;
- Dogliotti, L.;
- Angeli, A.
Publication type:
Article
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.
Published in:
2008
By:
- Generali, D.;
- Dovio, A.;
- Tampellini, M.;
- Tucci, M.;
- Tedoldi, S.;
- Torta, M.;
- Bonardi, S.;
- Allevi, G.;
- Aguggini, S.;
- Milani, M.;
- Harris, A. L.;
- Bottini, A.;
- Dogliotti, L.;
- Angeli, A.;
- Berruti, A.
Publication type:
journal article
Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer.
Published in:
2003
By:
- Bottini, A.;
- Berruti, A.;
- Brizzi, M.P.;
- Bersiga, A.;
- Generali, D.;
- Allevi, G.;
- Aguggini, S.;
- Bolsi, G.;
- Bonardi, S.;
- Bertoli, G.;
- Alquati, P.;
- Dogliottu, L.;
- Dogliotti, L
Publication type:
journal article
Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer.
Published in:
British Journal of Cancer, 2001, v. 85, n. 8, p. 1106, doi. 10.1054/bjoc.2001.2048
By:
- Bottini, A;
- Berruti, A;
- Bersiga, A;
- Brizzi, M P;
- Bruzzi, P;
- Aguggini, S;
- Brunelli, A;
- Bolsi, G;
- Allevi, G;
- Generali, D;
- Betri, E;
- Bertoli, G;
- Alquati, P;
- Dogliotti, L
Publication type:
Article

Found: 6

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer.

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.

Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.

Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.

Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer.

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer.